Award
NIH Reporter #5R01NS134116-04
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
Recipient
Beckman Research Institute/City of Hope, Duarte, CA, United States
Award Amount
$571,835.00
Ceiling
$571,835.00
Awarded
August 14, 2026
Identifier
5R01NS134116-04
NIH research grant awarded to Beckman Research Institute/City of Hope to study and develop therapies targeting RAGE to enhance glioma immunotherapy effectiveness.
Description
Research grant project focused on developing drugs that selectively inhibit the activity of RAGE in glioblastoma tumors to improve immunotherapy efficacy and address treatment resistance mechanisms in glioblastoma.